REGISTERED
on 14 Dec 2021
Last Applicant/ Owned by
4455 GENESEE STREET
BUFFALO
NY
14225
Serial Number
88756309 filed on 13th Jan 2020
Registration Number
6591111 registered on 14th Dec 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
VAZALORE
Aspirin-based analgesic, anti-pyretic and anti-inflammatory oral preparations in liquid-filled capsules and oral preparations in liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention
Classification Information
Class [005]
Pharmaceutical Products
Aspirin-based analgesic, anti-pyretic and anti-inflammatory oral preparations in liquid-filled capsules and oral preparations in liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention
First Use Date in General
14th Aug 2021
First Use Date in Commerce
14th Aug 2021
Mark Details
Serial Number
No 88756309
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 11577.011 en
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
02.11.01 -
Hearts
02.11.13 -
Hearts used as background or carriers
17.07.25 -
Other measuring instruments and markers, including seismographs, Geiger counters and windsocks
26.17.10 -
Zig-zag line(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Sep 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 02th Jun 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 02th Jun 2022 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 04th Jan 2022 | TEAS SECTION 7 REQUEST RECEIVED |
| 14th Dec 2021 | REGISTERED-PRINCIPAL REGISTER |
| 12th Nov 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 11th Nov 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 09th Nov 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| 05th Nov 2021 | TEAS STATEMENT OF USE RECEIVED |
| 05th Nov 2021 | USE AMENDMENT FILED |